References
- [1] CHIB, S.-GREENBERG, E.: Understanding the metropolis-hastings algorithm, Amer. Statist. 49 (1995), 327-335.
- [2] GELFAND, A. E.-SMITH, A. F. M.: Sampling-based approaches to calculating marginaldensities, J. Amer. Statist. Assoc. 85 (1990), 398-409.
- [3] KLEIN, J. P.-MOESCHBERGER, M. L.: Survival Analysis: Techniques for Censored and Truncated Data. Springer-Verlag, New York, NY, 1997.
- [4] LAMBERT, P. C.-DICKMAN, P. W.-WESTON, C. L.-THOMPSON, J. R.: Estimatingthe cure fraction in population-based cancer studies by using finite mixture models, J. Roy. Stat. Soc. Ser. C 59 (2010), 35-55.
- [5] MALLER, R. A.-ZHOU, X.: Survival Analysis with Long-Term Survivors. John Wiley & Sons Ltd., Chichester, 1996.
- [6] SAS: The MCMC Procedure, SAS/STATR User’s Guide, Version 9.22, Cary, NC: SAS Institute Inc., 2010, 4102-4326.
- [7] SPIEGELHALTER, D.-BEST, N.-CARLIN, B.-VAN DER LINDE, A.: Bayesianmeasures of model complexity and fit, J. R. Stat. Soc. Ser. B, Methodol. 64 (2002), 583-639.
- [8] TSODIKOV, A. D.-IBRAHIM, J. G.-YAKOVLEV, A. Y.: Estimating cure rates fromsurvival data: an alternative to two-component mixture models, J. Amer. Statist. Assoc. 98 (2003), 1063-1078.
- [9] WIENKE, A.-LOCATELLI, I.-YASHIN, A. I.: The modelling of a cure fraction inbivariate time-to-event data, Austrian J. Statist. 35 (2006), 67-76.
- [10] YAKOVLEV, A.-TSODIKOV, A. D.: Stochastic Models of Tumor Latency and Their Biostatistical Applications, World Scientific, Singapore, 1996.